INFANT FORMULAS CONTAINING DOCOSAHEXAENOIC ACID AND LUTEIN
    2.
    发明申请
    INFANT FORMULAS CONTAINING DOCOSAHEXAENOIC ACID AND LUTEIN 审中-公开
    含DOCOSAHEXAENOIC酸和叶黄素的婴儿配方奶粉

    公开(公告)号:WO2007050521A2

    公开(公告)日:2007-05-03

    申请号:PCT/US2006/041303

    申请日:2006-10-23

    Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.

    Abstract translation: 公开了婴儿配方和使用它们促进婴儿视网膜健康和视力发育的相应方法。 该配方不含蛋黄磷脂并且包含脂肪,蛋白质,碳水化合物,维生素和矿物质,包括二十二碳六烯酸,并且在即食型基础上至少约50微克/升叶黄素,其中重量比 叶黄素(mcg)与二十二碳六烯酸(mg)的重量比为约1:2至约10:1。 这些配方也被认为对降低早产儿早产儿视网膜病的风险特别有用。

    LOW CALORIE INFANT FORMULA CONTAINING
    3.
    发明申请
    LOW CALORIE INFANT FORMULA CONTAINING 审中-公开
    低CALORIE婴儿配方包含

    公开(公告)号:WO2014152616A1

    公开(公告)日:2014-09-25

    申请号:PCT/US2014/027534

    申请日:2014-03-14

    Abstract: Preterm infant nutritional compositions comprising beta-hydroxy-beta-methylbutyric acid for supporting growth, accretion of lean body mass, and a healthy body composition in preterm infants are provided. The preterm infant nutritional compositions may be liquid formulas, fortifiers, and supplements. Methods for supporting growth, accretion of lean body mass, and a healthy body composition in a preterm infant are also provided. The methods include administering a preterm infant nutritional composition comprising beta-hydroxy-beta-methylbutyric acid to the preterm infant.

    Abstract translation: 提供了包含用于支持生长的β-羟基-β-甲基丁酸的早产儿营养组合物,瘦体重的增加以及早产儿的健康的身体组成。 早产儿营养组合物可以是液体配方,强化剂和补充剂。 还提供了用于支持早产儿中生长增加,瘦体重增加和健康身体组成的方法。 所述方法包括向早产婴儿施用包含β-羟基-β-甲基丁酸的早产儿营养组合物。

    METHOD OF REDUCING THE RISK OF RETINOPHATHY OF PREMATURITY IN PRETERM INFANTS
    7.
    发明申请
    METHOD OF REDUCING THE RISK OF RETINOPHATHY OF PREMATURITY IN PRETERM INFANTS 审中-公开
    降低前列腺疾病预后的风险的方法

    公开(公告)号:WO2008082946A1

    公开(公告)日:2008-07-10

    申请号:PCT/US2007/087874

    申请日:2007-12-18

    Abstract: Disclosed is a method of reducing the risk or severity of retinopathy of prematurity in preterm infants. The method comprises (a) measuring skin carotenoid levels in preterm infants, preferably by Raman Spectroscopy, and then (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, lycopene, beta-carotene, and zeaxanthin. The supplemental carotenoids may be provided by an infant formula comprising, on a ready-to-feed basis, from about 100 to about 2000 meg/liter of total carotenoids, wherein the total carotenoids include at least about 50 mcg/hter of lutein. The formulas may further comprise docosahexaenoic acid.

    Abstract translation: 公开了一种降低早产儿早产儿视网膜病变风险或严重程度的方法。 该方法包括:(a)优选通过拉曼光谱法测定早产儿的皮肤类胡萝卜素水平,然后(b)向有需要的那些婴儿施用补充类胡萝卜素,其中补充的类胡萝卜素包括叶黄素,番茄红素,β-胡萝卜素和玉米黄质。 补充的类胡萝卜素可以由婴儿配方提供,其包括在即食物基础上约100至约2000mcg的总类胡萝卜素,其中总类胡萝卜素包括至少约50mcg / hter的叶黄素。 配方还可以包含二十二碳六烯酸。

    IRON-CONTAINING HUMAN MILK FORTIFIER WITH IMPROVED ANTIMICROBIAL PROPERTIES

    公开(公告)号:WO2005051088A3

    公开(公告)日:2005-06-09

    申请号:PCT/US2004/035505

    申请日:2004-10-26

    Abstract: Disclosed are human milk fortifier compositions, in either powder or liquid forms, comprising nutrients and selected iron-containing materials, wherein the fortifiers when added to human milk do not significantly inhibit or otherwise eliminate the inherent, in-vitro antimicrobial properties of the milk. This is accomplished by formulating the compositions with iron-containing insoluble iron, soluble bound iron, or combinations thereof, with little or no soluble unbound iron. Also disclosed are methods of providing nutrition to infants, especially preterm infants, by adding the human milk fortifier described herein with human milk to form a fortified human milk, and then administering the fortified human milk to the infant. The fortifier can also be used to fortify other infant formulas.

Patent Agency Ranking